Deaths from lung cancer could be reduced by better policies to control indoor radonJanuary 07, 2009Research paper: Lung cancer deaths from indoor radon and the cost-effectiveness and potential of policies to reduce them About 1100 people each year die in the UK from lung cancer related to indoor radon, but current government protection policies focus mainly on the small number of homes with high radon levels and neglect the 95% of radon related deaths caused by lower levels of radon, according to a study published on bmj.com today. The authors argue that installing basic and cheap measures to prevent radon in all new homes would be more cost-effective and have greater potential for reducing lung cancer deaths caused by radon, and UK Building Regulations should be amended to enforce this. Radon in the home is a natural air pollutant produced by the decay of uranium in the ground. Radon gas seeps into buildings through cracks and holes in the foundations and when it decays it produces particles that can enter the lungs and expose them to damaging radiation. At present, government policies in the UK concentrate on searching for homes with high levels of radon and encouraging homeowners to take remedial action at their own expense. Professor Alastair Gray, Professor Sarah Darby and other colleagues from the University of Oxford, assessed the contribution of indoor radon to lung cancer deaths in the UK, and examined the cost- effectiveness of policies to control radon exposure. They used recent evidence on the risk of lung cancer from indoor radon, based on data from 7,000 people with lung cancer and more than 21,000 people without lung cancer across Europe. They then calculated the lifetime risk of lung cancer death before and after various interventions to control radon, and the costs involved. The authors estimate that 1100 deaths a year in the UK are related to radon, about 3.3% of all deaths from lung cancer, but less than 5% of radon related deaths occur from exposure above the current action level. In addition, they report that many homeowners refuse to have their home tested or to spend money reducing radon levels. As a result these policies are costly and have a minimal impact on radon related deaths. In contrast, the authors found that installing simple preventive measures in new homes is highly cost-effective, but at present is only being done in selected areas of the country. This should be rolled out across the whole UK, say the authors, and should be backed up by changes to the Building Regulations. A gas-resistant membrane in the foundations would reduce radon by about 50% and would cost only about £100. Importantly, the study also found that six out of seven radon related lung cancers occur in people who smoke or who have smoked in the past. The best way for current smokers to reduce risk is to stop smoking. Current and former smokers can also reduce their risk by taking radon control measures seriously, say the authors. The authors suggest that their findings are relevant to many other countries, most of which have higher concentrations of radon than the UK. The average radon concentration in UK homes is 21 bequerels per cubic metre, but in the European Union the average is 55, suggesting that about 8% of deaths from lung cancer, or 18,000 deaths each year, are caused by radon across the EU. This is the most extensive and detailed evaluation to date of the policies to counter radon-induced and deaths from lung cancer, say Professor Anssi Auvinen from the University of Tampere in Finland and Professor Göran Pershagen from the Institute of Environmental Medicine in Sweden, in an accompanying editorial. The findings suggest that:"Radon policies need to be scrutinised [and particularly in populations with low average levels], the priority should be to apply basic measures universally rather than to take action only when high radon levels have been identified by measurement." BMJ-British Medical Journal |
|||||||||||||||||||||
| Related Lung Cancer Current Events and Lung Cancer News Articles Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Common pain relief medication may encourage cancer growth Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells. Study raises concerns about outdoor second-hand smoke Indoor smoking bans have forced smokers at bars and restaurants onto outdoor patios, but a new University of Georgia study in collaboration with the Centers for Disease Control and Prevention suggests that these outdoor smoking areas might be creating a new health hazard. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. PET imaging response a prognostic factor after thoracic radiation therapy for lung cancer A rapid decline in metabolic activity on a PET scan after radiation therapy for non-small cell lung cancer is correlated with good local tumor control, according to a study presented by researchers at Thomas Jefferson University Hospital at the 51st ASTRO Annual Meeting. Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer Treating limited stage small cell lung cancer(LSCL) with a combination of accelerated high-dose radiotherapy and chemotherapy has shown encouraging results. Stereotactic radiotherapy offers noninvasive, effective treatment for frail patients with early-stage lung cancer Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians. Preventative brain radiation for lung cancer patients: Benefits and risks A new study is taking a closer look at the benefits versus risks for lung cancer patients to undergo preventative brain radiation therapy as a means to stop cancer from spreading to the brain. Study spotlights efficacy of questionnaire to identify patients at high risk for lung cancer A study featured in the November issue of the Journal of Thoracic Oncology confirms the success of a simple questionnaire designed to identify patients at high risk of lung cancer. Intervals between lung cancer diagnosis and treatment displays a health care disparity Research published in the November 2009 issue of the Journal of Thoracic Oncology has found that intervals between lung cancer suspicion, diagnosis and treatment may be attributed to health care system discrepancies. More Lung Cancer Current Events and Lung Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||